Avi RavalManaging Director, Advisory
Mr. Raval is a Managing Director in Perella Weinberg Partners’ Advisory business. He focuses on advising clients in the Healthcare industry.
Mr. Raval has more than 14 years of investment banking experience assisting companies on a wide range of strategic matters. During his tenure at Perella Weinberg Partners, he has advised a number of clients including Medtronic on its acquisition of Mazor Robotics; Cardinal Health on its acquisition of Medtronic’s Patient Recovery business; HeartWare on its sale to Medtronic; Wright Medical on its merger with Tornier; CareFusion on its sale to BD; Medtronic on its acquisition of Covidien; and Shockwave, Novocure, and Penumbra on their IPOs.
Prior to joining Perella Weinberg Partners in 2012, Mr. Raval was at J.P.Morgan from 2005 to 2012, where he most recently served as an Executive Director responsible for advising a broad range of Healthcare clients on M&A and capital raising transactions. He was previously a Product Manager at Pinnacor. Mr. Raval began his career as a Business Analyst at Mitchell Madison Group.
Mr. Raval earned a Bachelor of Arts in Neuroscience and Economics from the University of Pennsylvania and a Masters of Business Administration from the Wharton School at the University of Pennsylvania.